Css LLC Mirati Therapeutics, Inc. Put Options Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $19 Million - $28.2 Million	452,700 New	452,700 $26.6 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $119,000 - $173,400	2,000 Added 71.43%	4,800 $335,000
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $109,647 - $248,387	2,800 New	2,800 $188,000
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $514,838 - $742,131	-3,900 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $462,455 - $621,075	3,500 Added 875.0%	3,900 $690,000
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $63,567 - $88,644	400 New	400 $69,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.